Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Fred Hassan
AddedMar 31, 2024
UpdatedMay 1, 2026
Fred Hassan

Fred Hassan

Board Member, Amgen Ventures

Fred Hassan's Career

Amgen Ventures
Amgen Ventures

Thousand Oaks, CA, US

Board Member· Board
Cocrystal Pharma
Cocrystal Pharma

Tucker, GA, US

Board Member· Board
BridgeBio Pharma
BridgeBio Pharma

Palo Alto, CA, US

Board Member· Board
Precigen
Precigen

Germantown, MD, US

Board Member· Board
Modernizing Medicine
Modernizing Medicine

Boca Raton, FL, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Fred Hassan's Career

Amgen Ventures
Amgen Ventures
Investment FirmInvestment Firm$28.5B25.2k2004Thousand Oaks, CA, US
Board Member· Board

Leadership at Amgen Ventures

Robert A. BradwayRobert A. BradwayBoard Member
Ronald D. SugarRonald D. SugarBoard Member
Elliott SigalElliott SigalBoard Member
Ellen KullmanEllen KullmanBoard Member
Frank HerringerFrank HerringerBoard Member
Greg C. GarlandGreg C. GarlandBoard Member

Similar to Amgen Ventures

5AM Ventures5AM VenturesMenlo Park, CA, USest. 20025AM VenturesMenlo Park, CA, US · est. 2002

5AM: A diversified biopharmaceutical investment fund pioneering in advanced life science innovations since 2002.

Investment Firm49
AbbVie Biotech VenturesAbbVie Biotech VenturesChicago, IL, USest. 2009AbbVie Biotech VenturesChicago, IL, US · est. 2009

ABVI: A US-based venture capital firm specializing in investments in biotech and pharmaceutical sectors.

Investment Firm10k
Illumina VenturesIllumina VenturesFoster City, CA, USest. 2015Illumina VenturesFoster City, CA, US · est. 2015

Illumina Ventures: Enhancing human health through powerful genomics solutions.

Investment Firm24
McKesson VenturesMcKesson VenturesSan Francisco, CA, USest. 2014McKesson VenturesSan Francisco, CA, US · est. 2014

McKesson Ventures LLC: A US-based venture capital firm specializing in early-stage healthcare technology and services.

Investment Firm12
Cocrystal Pharma
Cocrystal Pharma
Public122014Tucker, GA, US
Board Member· Board

Leadership at Cocrystal Pharma

Roger KornbergRoger KornbergBoard Member
Steve RubinSteve RubinBoard Member
Jim MartinJim MartinCEO
BridgeBio Pharma
BridgeBio Pharma

Palo Alto, CA, US

Board Member· Board
Precigen
Precigen
Public$600.8M1381998Germantown, MD, US
Board Member· Board

Leadership at Precigen

Robert ShapiroRobert ShapiroBoard Member
Cesar AlvarezCesar AlvarezBoard Member
Randal J. KirkRandal J. KirkBoard Member
Dean J. MitchellDean J. MitchellBoard Member
Jeffrey B. KindlerJeffrey B. KindlerBoard Member
Thomas D. ReedThomas D. ReedBoard Member
Modernizing Medicine
Modernizing Medicine
Series D$385.9M1.6k2010Boca Raton, FL, US
Board Member· Board

Leadership at Modernizing Medicine

Michael SherlingMichael SherlingCo-Founder
Mark A. deLaarMark A. deLaarBoard Member
Amr KronfolAmr KronfolBoard Member
Daniel CaneDaniel CaneCo-Founder & CEO

Similar to Modernizing Medicine

MeditechMeditechWestwood, MA, USServices, Softwareest. 1969MeditechWestwood, MA, US · est. 1969

Meditech: A Massachusetts-based private firm providing healthcare information systems and services.

Series B · $26M3.7k
DoximityDoximitySan Francisco, CA, USNetworking, Telehealthest. 2010DoximitySan Francisco, CA, US · est. 2010

Doximity, based in San Mateo, US, is a networking service providing curated medical news, telehealth tools, and collaboration for professionals.

Public · $81.8M977
DrFirst.comDrFirst.comRockville, MD, USHealthcare Softwareest. 2000DrFirst.comRockville, MD, US · est. 2000

Providing efficient, secure healthcare software solutions for seamless patient care.

Series D · $202.6M152
Medsphere SystemsMedsphere SystemsCarlsbad, CA, USEHR, Healthcare ITest. 2002Medsphere SystemsCarlsbad, CA, US · est. 2002

Medsphere, a leading provider of open-source healthcare IT solutions, offers advanced EHR systems, revenue cycle management, and IT services for healthcare organizations.

Private Equity · $134.2M170

Fred Hassan's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Fred Hassan

Frank FischerFrank FischerBoard Member · Babson CollegeFred DotzlerFred DotzlerBoard Member · Bayhill TherapeuticsDavid SidranskyDavid SidranskyBoard Member · Galmed PharmaceuticalsGreg MaddenGreg MaddenBoard Member · AlloCureJohn FriederyJohn FriederyBoard Member · FlowserveTony BroglioTony BroglioBoard Member · MediaAlpha